Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: Cross-sectional survey

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 7, 2015, Pages 816-823

  Patel, Purav ^a,b   Bercik, Premysl ^c   Morgan, David G ^d   Bolino, Carolina ^c   Pintos Sanchez, Maria Ines ^c   Moayyedi, Paul ^c   Ford, Alexander C ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Abdominal pain; Hard stools; Loose stools; Straining

Indexed keywords

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL CANCER; CONSTIPATION; CROHN DISEASE; DIAGNOSTIC VALUE; DIARRHEA; DISEASES; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; ORGANIC DISEASE; PREVALENCE; PRIORITY JOURNAL; ULCERATIVE COLITIS; ABDOMINAL PAIN; ADOLESCENT; AGED; BIOPSY; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL DISEASES; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COLONOSCOPY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84929208655     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1007079     Document Type: Article

References (26)

1. Lovell RM, Ford AC. Global prevalence of, and risk factors for, irritable bowel syndrome: A meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-21.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
3. American College of Gastroenterology IBSTF. An evidencebased position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104:S1-7.
4. Spiller R, Aziz Q, Creed FEA, Houghton L, Hungin P, Jones R, et al. Guidelines on the irritable bowel syndrome: Mechanisms and practical management. Gut 2007;56: 1770-98.
5. Begtrup LM, Engsbro AL, Kjeldsen J, Larsen PV, Schaffalitzky de Muckadell O, Bytzer P, et al. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013;11:956-62.
6. Drossman DA, Thompson WG. The irritable bowel syndrome: Review and a graduated multicomponent treatment approach. Ann Intern Med 1992;116:1009-16.
7. Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Naliboff B, et al. Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? Gastrointest Endosc 2005;62: 892-9.
8. Sanders DS, Carter MJ, Hurlstone DP, Pearce A, Milford Ward A, McAlindon ME, et al. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001;358:1504-8.
9. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BMR, Moayyedi P. Yield of diagnostic tests for celiac disease in subjects with symptoms suggestive of irritable bowel syndrome: Systematic review and meta-analysis. Arch Intern Med 2009;169:651-8.
10. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009;30:707-17.
11. Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012;24:983-e538.
12. Bajor A, Kilander A, Fae A, Galman C, Jonsson O, Ohman L, et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur J Gastroenterol Hepatol 2006;18:397-403.
13. Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: A prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157-60.
14. Ford AC, Spiegel BMR, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: Systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009;7:1279-86.
15. Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celia disease: Ameta-analysis. ClinGastroenterolHepatol2012;11:359-65.
16. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-analysis. Am J Gastroenterol 2012;107:1474-82.
17. Abboud R, Pardi DS, Tremaine WJ, Kammer PP, Sandborn WJ, Loftus EV Jr. Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study. Inflamm Bowel Dis 2013;19:550-3.
18. Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI,Moayyedi P. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013;145:1262-70.
19. Chey WD, Nojkov B, Rubenstein JH, Dobhan R, Greenson JK, Cash BD. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: Results from a prospective, controlled US trial. Am J Gastroenterol 2010; 105:859-65.
20. Ishihara S, Yashima K, Kushiyama Y, Izumi A, Kawashima K, Fujishiro H, et al. Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy. J Gastroenterol 2012;47:1084-90.
21. Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. The Rome III criteria for the diagnosis of functional dyspepsia in secondary care are not superior to previous definitions. Gastroenterology 2014;146: 932-40.
22. Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Characteristics of functional bowel disorder patients: A cross-sectional survey using the Rome III criteria. Aliment Pharmacol Ther 2014;39:312-21.
23. Whitehead WE. and the Validation Working Team Committee in association with the Rome Questionnaire C. Development and validation of the Rome III diagnostic questionnaire. In Drossman DA, editor. Rome III: The functional gastrointestinal disorders. 3rd edition. Virginia: Degnon Associates, Inc; 2006. p 835-53.
24. Limsui D, Pardi DS, Camilleri M, Loftus EV, Kammer PP, Tremaine WJ, et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175-81.
25. Ford AC, Veldhuyzen Van Zanten SJO, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: Systematic review and metaanalysis. Gut 2008;57:1545-53.
26. Ford AC, Talley NJ, Veldhuyzen Van Zanten SJ, Vakil NB, Simel DL, Moayyedi P. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA 2008;300:1793-805.